Autoimmune, pemphigus, dermatology, medical odyssey, oral health mystery, oral health, blisters, OASIS, Lupus, Sjogren's, ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

Autoimmune diseases like Sjögren’s syndrome, lupus, rheumatoid arthritis, Guillain-Barré syndrome, chronic inflammatory ...

Tailoring rituximab treatment among patients with pemphigus based on the presence of predictors of early relapse reduced relapse rates at 12 months.

Issues to be addressed when evaluating a patient for pemphigus include the age of onset, previous clinical symtoms, initial presentation, presence of mucous membrane symptoms and the presence of ...